Episode

The big shrink

Podcast
Reuters Econ World
Published
Feb 18, 2026
Duration seconds
2048
Processing state
not_requested
Canonical source
https://pdst.fm/e/traffic.megaphone.fm/THRH4680350290.mp3?updated=1771431861
Audio
https://pdst.fm/e/traffic.megaphone.fm/THRH4680350290.mp3?updated=1771431861
JSON
/v1/public/podcasts/reuters-econ-world-6911110/episodes/the-big-shrink
Markdown
/podcast/reuters-econ-world-6911110/the-big-shrink.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/reuters-econ-world-6911110/episodes/the-big-shrink/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/reuters-econ-world-6911110/the-big-shrink.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Will weight-loss drugs fuel the global economy, or give it indigestion? Host Carmel Crimmins talks to Michele Gershberg, global health editor and U.S. business editor David Gaffen about the impact of falling obesity rates on consumer spending, productivity and government finances. Sign up for the ⁠⁠Reuters Econ World ⁠⁠⁠newsletter⁠⁠⁠⁠ Produced by Eliza Davis Beard Sound engineering and music by Josh Sommer Visit the ⁠Thomson Reuters Privacy Statement⁠ for information on our privacy and data protection practices. You may also visit ⁠megaphone.fm/adchoices⁠ to opt out of targeted advertising. Our Standards: ⁠**The Thomson Reuters Trust Principles.⁠** Further listening Dating apps Is Big Tech too big to slow down? Labor market limbo ⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices